Protara Therapeutics (TARA) Shares Outstanding (2013 - 2026)

Protara Therapeutics' Shares Outstanding history runs 14 years deep, the most recent figure standing at $55.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 42.71% year-over-year to $55.1 million; the TTM figure through Mar 2026 stood at $55.1 million (up 42.71% YoY), while the FY2025 annual figure was $53.6 million, up 52.91% from the prior year.
• Shares Outstanding was $55.1 million for Q1 2026 at Protara Therapeutics, up from $53.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $55.1 million in Q1 2026 to a low of $5615.0 in Q1 2025.
• Historically, Shares Outstanding has averaged $15.3 million across 5 years, with a median of $11.3 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding sank 99.93% in 2023, then jumped 482665.77% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $8027.0 in 2022, then declined by 0.45% to $7991.0 in 2023, then soared by 438453.02% to $35.0 million in 2024, then soared by 52.91% to $53.6 million in 2025, then advanced by 2.74% to $55.1 million in 2026.
• The last three Shares Outstanding figures came in at $55.1 million (Q1 2026), $53.6 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.